Objectives To evaluate if computer-aided diagnosis (CAD) prior to prostate multi-parametric MRI (mpMRI) can improve sensitivity and agreement between radiologists. Methods Nine radiologists (three each high, intermediate, low experience) from eight institutions participated. A total of 163 patients with 3-T mpMRI from 4/2012 to 6/2015 were included: 110 cancer patients with prostatectomy after mpMRI, 53 patients with no lesions on mpMRI and negative TRUS-guided biopsy. Readers were blinded to all outcomes and detected lesions per PI-RADSv2 on mpMRI. After 5 weeks, readers re-evaluated patients using CAD to detect lesions. Prostatectomy specimens registered to MRI were ground truth with index lesions defined on pathology. Sensitivity, specificity and agreement were calculated per patient, lesion level and zone-peripheral (PZ) and transition (TZ). Results Index lesion sensitivity was 78.2% for mpMRI alone and 86.3% for CAD-assisted mpMRI (p = 0.013). Sensitivity was comparable for TZ lesions (78.7% vs 78.1%; p = 0.929); CAD improved PZ lesion sensitivity (84% vs 94%; p = 0.003). Improved sensitivity came from lesions scored PI-RADS < 3 as index lesion sensitivity was comparable at PI-RADS ≥ 3 (77.6% vs 78.1%; p = 0.859). Per patient specificity was 57.1% for CAD and 70.4% for mpMRI (p = 0.003). CAD improved agreement between all readers (56.9% vs 71.8%; p < 0.001). Conclusions CAD-assisted mpMRI improved sensitivity and agreement, but decreased specificity, between radiologists of varying experience. Key Points • Computer-aided diagnosis (CAD) assists clinicians in detecting prostate cancer on MRI.
Introduction
Prostate cancer remains a significant cause of cancer mortality in the USA, with 26,120 deaths estimated in 2016 [1] . Contributing to the mortality rate is the underdiagnosis of aggressive disease through systematic transrectal ultrasound (TRUS) biopsy [2 -4 ] . Multi-parametric mpMRI (mpMRI)-guided biopsies are a possible solution to this problem and have been shown to limit overdetection of indolent prostate cancer while improving the detection of aggressive tumors [5] [6] [7] . While mpMRI-guided biopsies detect more clinically significant cancer, a subset of patients remains with undiagnosed, clinically significant tumors. Recent series on mpMRI fusion biopsies show a sensitivity between 77% and 84% for clinically significant tumors [6, 8] and a miss rate of index lesions on prostatectomy of 11.3-25.2% [9, 10] . This miss rate is multifactorial, but contributing factors for radiologists likely include overlooked lesions, steep learning curve and variability among radiologists [11, 12] .
One approach to improve the sensitivity and interobserver agreement of mpMRI is with computer-aided diagnosis (CAD) [13] . The designs of individual CAD systems vary, but the general approach is to extract features of mpMRI from T2-weighted (T2W), diffusion-weighted imaging (DWI) and/ or dynamic contrast-enhanced (DCE) images and train a computer algorithm to display areas of high cancer probability [14] . CAD systems have shown promising results with area under the curve (AUC) values ranging from 0.80 to 0.89 for the detection of prostate cancer [13, [15] [16] [17] [18] [19] [20] . However, little research has explored how radiologists interact with CAD systems [21] . In particular, CAD systems have not been evaluated in a Bfirst-reader^design where CAD is first presented followed by conventional mpMRI interpretation. This workflow would theoretically simulate the raw performance of CAD as interpreted by radiologists, decrease variability between readers and increase sensitivity by removing preconception of a case by seeing MRI first [22] .
We sought to evaluate if CAD prior to the conventional interpretation of mpMRI of the prostate can improve the sensitivity for index lesions and agreement between radiologists.
Materials and methods

Patient population
This Health Insurance Portability and Accountability Act-compliant retrospective study was approved by the local ethics committee. All patients underwent mpMRI with T2W, DWI (ADC maps and b-2000 DWI) and DCE with endorectal coil at 3-T mpMRI. We included patients with prostate cancer treated by prostatectomy after mpMRI between 04/2012 and 06/2015 (n = 179). To limit detection bias, a group of patients between 05/2013 and 05/2015 with no lesions on mpMRIs obtained as part of clinical workup due to elevated serum PSA and negative TRUS-guided biopsies were selected as controls (n = 92). Patients were excluded for hip prosthesis or for missing sequences on mpMRI (n = 6); cancer patients were excluded if whole mount specimens were not available (n = 66). The ratio of cancer to control patients was selected to be 2:1 and control patients were randomly excluded to reach this ratio (n = 35). Two control patients were excluded for converting to a positive biopsy during the course of the study (total exclusions = 69 cases, 39 controls). The total study population was 163 (n = 110 cases; n = 53 controls). Patient characteristics are shown in Table 1 .
Radiologist profile
Nine radiologists agreed to participate. Three were highly experienced in prostate mpMRI (> 2000 cases), three were moderately experienced (500-1000 cases) and three were novices (< 500 cases). Readers represented six countries and eight institutions. All had experience with PI-RADSv2 prior to this study and none used a CAD system as part of prostate mpMRI evaluation prior to this study.
Study design and statistical power
Our primary hypothesis was that CAD-assisted mpMRI (CAD) would improve the sensitivity over mpMRI alone (mpMRI). To test this hypothesis while limiting the number of reads volunteer radiologists needed to interpret, a hybrid design was used in which a portion of all patients would be evaluated by all readers, and the remaining would be evaluated by allocating patients to pairwise combinations of readers while maintaining a 2:1 ratio of cancer to control patients. Of the 163 patients, 21 randomly selected patients with cancer and seven randomly selected control patients were evaluated by all nine readers. Each pairwise combination of readers evaluated at least 2-3 patients. Each reader evaluated an average of 58 patients (range 56-60).
The difference in average reader-specific sensitivity between CAD and mpMRI was the primary endpoint. We used in-house data to estimate the average sensitivity for all lesions at 55% for mpMRI. As the CAD-assisted mpMRI would detect more lesions, its sensitivity was expected to be higher defined as 10% improvement. Under the hybrid design the study had 92% power to detect a 10% difference in sensitivity using the Z test at the two-sided 5% significance level.
MR imaging
The prostate mpMRI scans were acquired on a 3-T scanner (Achieva 3.0T-TX, Philips Healthcare, Best, Netherlands) using an endorectal coil (BPX-30, Medrad, Pittsburgh, PA, USA) filled with approximately 45 ml Fluorinert (3M, Maplewood, MN, USA) and the anterior half of a 32-channel cardiac SENSE coil (InVivo, Gainesville, FL, USA). Supplemental Table 1 contains the sequences and mpMRI acquisition parameters used in this study.
CAD map
The CAD map was a system based on a random forest classifier [23] . T2W, ADC, b-2000 DWI and segmentation of the whole prostate and transition zone are inputs. Segmentation was automated using commercial software on axial T2W images (iCAD, Nashua, New Hampshire). Segmentations showing gross distortions were refined by a prostate mpMRI research fellow with experience in segmenting more than 100 patients. Gross distortions were present on 5/163 patients. As T2W and DWI were acquired consecutively, minimal motion was assumed for transfer of segmentation. The classifier was trained on the basis of tumour segmentation (53 patients), mpMRI-TRUS fusion biopsy results (147 patients) and biopsy negative prostates (24 patients) and gave a probability map as output ( Fig. 1 ). Supplemental Table 2 shows the characteristics of training patients. There was no overlap between the training and study populations.
Image interpretation
Readers were blinded to all clinical and pathological outcomes. All DICOMs, stripped of patient information, were delivered to readers and viewed on personal workstations using RadiAnt Viewer [24] . In the first arm of the study, readers first detected up to four lesions per patient on mpMRI without CAD as would be included on a clinical report per PI-RADSv2 [25] . Readers recorded the PI-RADSv2 T2W, DWI, DCE score and the zone-peripheral (PZ) or transition (TZ)-for each lesion. Each lesion was marked with a measurement of the largest diameter. Readers saved a screenshot of the marked lesion and slice number for correlating lesions between readers. All data were recorded with a Microsoft Access application (Microsoft Access Professional Plus 2010, 14.0.7166.5000, 32-bit) programed to record time and ensure data validation (Fig. 2 ). Readers were asked to complete all reads at a typical clinical pace within a 2-month timeframe. Readers received no feedback on their performance.
After a 5-week washout, readers evaluated the same cases with the a priori assistance of CAD, i.e. as a Bfirst reader^. The same patients were presented in a random order with different pseudo-identifiers. Readers were first presented with CAD probability maps alone. Readers were instructed that the largest and most intensely red colour-coded lesions were most likely to represent cancerous lesions and were told to mark up to four lesions on CAD. After lesions were marked on CAD, readers evaluated the corresponding images on mpMRI and scored marked lesions with PI-RADSv2. This facilitated Bruling out^and Bruling in^lesions on CAD. No additional detected lesions on mpMRI were allowed after the initial selection of lesions on CAD. Before evaluating study patients in the CAD-assisted read out session each reader was given seven random cases that were not part of the study population to evaluate the features of CAD. They were not aware of clinical or histopathological data on these training cases, nor did they receive feedback on performance. Once readers evaluated the training cases, they evaluated each patient as in the first arm of the study. Readers recorded lesion screenshots, zone and PI-RADS scores. Lesion comparison between readers was made by an independent observer on the basis of screenshots, allowing for differences of up to two 3-mm mpMRI axial slices. If lesions were non-contiguous and more than two slices apart they were evaluated as different lesions.
Pathological validation
All cancer patients had whole-mount radical prostatectomy specimens processed with patient-specific mpMRI-based 3D-printed moulds [26] . Lesion location and Gleason score (GS) on whole-mount specimens were determined by a genitourinary pathologist as part of routine diagnosis of the patient without routine reference to mpMRI results. Comparison to pathology was performed on the basis of prostate landmarks and lesion morphology. Index lesions were defined on pathology as the lesion with the highest grade. If equivalent grade, the largest volume lesion was the index lesion.
Statistical analysis
For patient-based analysis, each patient's outcome for a given reader was the maximal PI-RADS score for that patient. Sensitivity and specificity were determined at each PI-RADS threshold and area under the curve (AUC) was estimated on the basis of the PI-RADS ≥ 3 threshold. As the CAD is not trained on qualitative PI-RADS scores, but on pathological results, CAD true positives may be called PI-RADS 1 or 2 by readers. Therefore, different PI-RADS thresholds for positivity (i.e. ≥ 1, 2, 3) were used for sensitivity and specificity analysis. For lesion-based analysis, reader sensitivities were determined. Both patient-based and lesion-based statistics were averaged across all readers and by experience. The 95% confidence intervals for all estimators were obtained from 2.5% and 97.5% percentiles of the bootstrap resampling distribution calculated from 2000 bootstrap samples by random sampling patients with Fig. 2 Application used to collect data. This standardized application that kept strict time of mpMRI and CAD reading times, allowed screenshot saving, and ensured data validation. It was created using Visual Basic for applications in Microsoft Access (please note that the patient medical record number (MRN) and name are all fictional). The paperclip indicates where the screenshot would appear Fig. 1 Probability maps of computer-aided diagnosis of prostate mpMRI. a CAD probability map and whole-mount pathology of a 67-year-old man with PSA 27.6 ng/mL. Gleason score of circumferential apical peripheral zone lesion was 4 + 4. b CAD probability map and whole-mount pathology of a 62-year-old man with PSA 6.23 ng/mL. Gleason score of left mid peripheral zone lesion was 4 + 3 replacement. For sensitivity and specificity, cancer patients and control patients were bootstrapped separately. Significance of the difference in sensitivity and specificity between CAD and mpMRI was tested by the Wald test. All p values correspond to two-sided tests, with a p value less than 0.05 considered to represent a significant difference.
Inter-observer agreement was examined on CAD vs mpMRI with respect to detection of lesions in the same location. Agreement on detection of lesions was calculated by the index of specific agreement (ISA), defined as the conditional probability given that one of the raters, randomly selected, detects a lesion that the other rater will also do so in the same location. The bootstrap resampling procedure described above was used for inference for ISA.
RESULTS
Lesion characteristics
Characteristics of lesions on pathology are shown in Table 2 . Readers identified more lesions on average on CAD than on mpMRI (2.16 vs 1.25, p < 0.001). Readers detected more lesions with CAD assistance in cancer patients (2.27 vs 1.59, p < 0.001) and in control patients (2.07 vs 0.63, p < 0.001).
Patient based analysis
The patient-level sensitivity, specificity and AUC of mpMRI vs CAD is shown in Table 3 . For all readers, sensitivity increased from 92.7% to 98.0% (p = 0.002) and specificity decreased from 54.2% to 16.0% (p < 0.001) with the assistance of CAD, considering all detected lesions (PI-RADS ≥ 1). Taking PI-RADS ≥ 3 as positive, the sensitivities of CAD and mpMRI were comparable at 90.3% vs 91.2% (p = 0.57), specificity remained higher for mpMRI, 70.4% vs 57.1% (p = 0.003) and AUC was comparable, 84.9% for CAD vs 88.2% for mpMRI (p = 0.098). Sensitivity increased for all experience levels; however, specificity was dependent on reader experience. On mpMRI alone, highly experienced readers reached a specificity of 91.0% compared to 50.9% and 69.3% for moderate and low experience readers, respectively. With CAD assistance, highly experienced readers reached a specificity of 65.8% vs 52.4% and 53.0% for moderate and low experienced readers, respectively.
Lesion based analysis
As shown in Table 4 , CAD improved the sensitivity for index lesions with an 8.1% mean increase (p = 0.013). Highly experienced readers showed improved sensitivity for index lesions from 81.0% to 88.7% (p = 0.06), moderately experienced from 77.6% to 87.3% (p = 0.041) and low experienced from 75.8% to 83.0% (p = 0.135). Readers marked the index lesion as dominant in 82.6% of CAD-and 88.7% of mpMRI-detected index lesions.
Sensitivity by PI-RADS score is shown in Fig. 3 . The average sensitivity for index lesions for all readers was 78.2% for mpMRI and 86.3% for CAD (p = 0.013) at PI-RADS ≥ 1. With PI-RADS ≥ 3 as positive, sensitivity for index lesions was 77.6% for mpMRI and 78.1% for CAD (p = 0.859). The same trend was observed for all lesions with a sensitivity for PI-RADS ≥ 1 of 59.9% CAD vs 51.6% mpMRI (p = 0.001) and for PI-RADS ≥ 3 48.9% CAD vs 49.7% mpMRI (p = 0.664). Figure 4 shows an example of CAD assistance to detect a lesion not seen on mpMRI.
Analysis by zone is shown in Fig. 5 . CAD in the PZ demonstrated improved sensitivity for index lesions from 84% to 92.9% (p = 0.003). For PI-RADS ≥ 3, sensitivity rose from 83.3% to 88.0% for CAD (p = 0.051), suggesting a benefit of CAD for index lesion detection and scoring in the PZ. The same benefit was not seen in the TZ, with equivalent sensitivity for index lesions, 78.1% mpMRI vs 78.7% CAD (p = 0.929).
Lesion-level specificity, or ability to identify a CAD false positive as PI-RADS 1 or 2 on mpMRI, was experience dependent. An average of 67.1 false positive lesions were selected by each reader on CAD, 62.7% in the TZ. As shown in Table 5 , highly experienced readers demonstrated a specificity of 75.9% vs 60.9% and 51.8% for moderate and low experience, respectively. Specificity was higher in the TZ than the PZ for all readers, 69.3% vs 51.3%, respectively. Specificity increased from 62.9% for PI-RADS ≥ 3 to 81.2% for PI-RADS ≥ 4 for both zones, with an increase from 69.3% to 89.1% in the TZ and 51.3% to 68.0% in the PZ. GS Gleason score, PZ peripheral zone, TZ transition zone
Inter-reader agreement
As shown in Fig. 6 , agreement in detecting a lesion (i.e. PI-RADS ≥ 1) in the same location increased from 56.9% to 71.8% (p < 0.001) with CAD assistance. Agreement in detecting index lesions increased from 87.1% to 93.7% (p = 0.028). Moderate and low experienced readers improved agreement with highly experienced readers with CAD assistance, improving from 57.7% to 72.6% (p < 0.01) and 59.8% to 72.5% (p < 0.01), respectively.
Interpretation times
The 
DISCUSSION
We observed an increase in sensitivity and agreement among nine radiologists across experience levels with CAD-assisted mpMRI over mpMRI alone. As more lesions were detected with CAD than mpMRI, CAD likely helped readers to overcome the Bsatisfaction of search^limitation which stems from reduced detection for subsequent lesions after one lesion [27] . This finding was particularly evident in the PZ with 9.0% improvement in sensitivity for index lesions. Readers across experience levels, including high experience, demonstrated improved sensitivity for index lesions with CAD at PI-RADS ≥ 1. This suggests that CAD enabled readers to detect index lesions that were outside PI-RADS parameters. CAD also improved reader agreement in lesion detection. Past research has suggested varying agreement among radiologists for prostate mpMRI [28, 29] . In our study, we found improved agreement for lesion detection with CAD assistance, increasing from 56.9% to 71.8%. With CAD assistance, less experienced readers agreed more frequently with highly experienced readers. Importantly, this is in lesion detection as no predefined lesions were shown to readers.
However, the improved sensitivity of CAD was balanced by decreased specificity. As this was an expected phenomenon, readers could Brule out^false positive lesions on CAD by scoring lesions on mpMRI with PI-RADSv2. With PI-RADS ≥ 3 considered positive, This CAD system used a random forest classifier based on texture and intensity features from T2W and DWI images and semi-automated segmentation [23] . Liu et al. [14] recently published an excellent review of prostate CAD systems. All studies have reported good AUC values ranging from 0.76 to 0.91 based on biopsy or prostatectomy validation. However, a paucity of data exists on how radiologists interact with these systems. Our study was not primarily designed to define the optimal CAD system, but rather suggests how CAD systems might be employed to assist readers. Some of the outcomes of this study are limited by the underlying performance of this CAD system and the Bfirst-readerd esign. A true clinical application may be a hybrid of CAD superimposed on mpMRI, similar to breast CAD systems.
The CAD system used in this study demonstrated better performance in the PZ and demonstrated a high level of false positives. We suspect that with a larger and more complete training set (24 non-diseased patients were included in the control training population for the classifier), the specificity of this CAD would improve. However, in this study readers across experience levels achieved higher levels of agreement with CAD assistance, suggesting a path towards standardization of prostate mpMRI interpretation. In addition, by limiting readers to only lesions detected on CAD, readers may have missed additional lesions not visible on CAD. We used this design to limit variability, to stringently test lesion detection capability of mpMRI vs. CAD-assisted mpMRI and selected a low positivity threshold on CAD for high sensitivity. This study has a number of limitations. All mpMRIs originated from a single institution. The CAD system may not demonstrate the same capability on images from other institutions. Our patient population was primarily limited to prostatectomy patients. These patients may have clearer mpMRI-detectable lesions than men with just elevated PSA across risk stratification. This could lead to a detection bias from the readers. We controlled for this by including patients with negative mpMRI and 12-core TRUS-guided biopsy. Cancer patients and control patients had statistically different PSA, prostate volume and age. This may have led to falsely elevated sensitivity and specificity, particularly on a patient level. We attempted to remediate this by blinding readers to all clinical outcomes. However, in a true clinical setting, PSA, volume, age and biopsy results would be known which may improve specificity. Finally, control patients were validated only by a negative mpMRI and TRUS biopsy. In addition, a number of control patients had a large time span between mpMRI and biopsy. Under current clinical practice, this was the best validation we could achieve.
In conclusion, by using a CAD system in a first-reader design, radiologists with different experience levels were able to detect index lesions with higher sensitivity and higher agreement in a similar amount of time as mpMRI alone. This finding has implications for improving the standardization of prostate mpMRI. High experience readers ruled out false positive lesions more effectively. All readers were more specific in the TZ WP whole prostate, PZ peripheral zone, TZ transition zone Fig. 6 Agreement between all readers for detecting all lesions and index lesions on mpMRI and on CAD for all readers and by all experience levels. Agreement between all readers increased with CAD assistance for all lesions and index lesions. Highly experienced readers demonstrated equivalent levels of agreement, whereas moderately experienced and low experienced readers had improved agreement. *Statistically significant differences at p < 0.05. HH agreement between high experience readers, HM agreement between high and moderate experience readers, HL agreement between high and low experienced readers
